We are live on ! Find out more
SRTS icon

Sensus Healthcare

3.19 USD
-0.07
2.15%
At close Updated Sep 4, 4:00 PM EDT
1 day
-2.15%
5 days
-10.39%
1 month
7.41%
3 months
13.12%
6 months
-27.66%
Year to date
-22.2%
1 year
0.31%
5 years
-9.63%
10 years
-48.13%
 

About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Employees: 60

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
MarketBeat
22 days ago
Sensus Healthcare Q2 Earnings Call Highlights
Sensus Healthcare NASDAQ: SRTS reported second-quarter revenue of $2.3 million, down from $7.3 million a year earlier, as delayed third-party financing prevented the company from recognizing revenue tied to eight equipment units before the end of June.
Sensus Healthcare Q2 Earnings Call Highlights
Neutral
Seeking Alpha
22 days ago
Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q2 2026 Earnings Call Transcript
Neutral
Business Wire
22 days ago
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended June 30, 2026. Highlights included: Revenues of $2.3 million for the quarter ended June 30, 2026, a decrease of $5.0 million, from the 2025 quarter. The decrease was driven by a lower number of un.
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
Neutral
Business Wire
1 month ago
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the second quarter of 2026 on Thursday, August 13, 2026. Management will hold a conference call beginning at 4:30 pm Eastern time to review the results, provide a business update and answer questions.Participants are enc.
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
Neutral
MarketBeat
3 months ago
Sensus Healthcare Q1 Earnings Call Highlights
Sensus Healthcare NASDAQ: SRTS said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year due largely to the absence of sales to its historically largest customer.
Sensus Healthcare Q1 Earnings Call Highlights
Neutral
Business Wire
4 months ago
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced that SkinCure Oncology and Sensus Healthcare have amicably resolved their dispute and are moving forward constructively with a shared commitment to patient care and clinical excellence. In March 2026, Sensus Healthcare filed a lawsuit in the Circuit Court for the Fifteenth Judicial Cir.
Sensus Healthcare Announces Amicable Resolution of Commercial Dispute with SkinCure Oncology
Neutral
Seeking Alpha
4 months ago
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q1 2026 Earnings Call Transcript
Neutral
Business Wire
4 months ago
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced financial results and business highlights for the three months ended March 31, 2026. Highlights included: Revenue of $3.4 million compared to $8.3 million for the three months ended March 31, 2025. Excluding sales to the Company's historically largest customer, rev.
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
Neutral
Business Wire
4 months ago
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company committed to providing highly effective, non-invasive treatments for oncological and non-oncological skin conditions, today announced the company will report financial results for the first quarter of 2026 on Thursday, May 7, 2026. Management will hold a conference call beginning at 4:30 pm Eastern time to review the results, provide a business update and answer questions. Participants are encour.
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
Neutral
Business Wire
5 months ago
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the filing of a lawsuit in the Circuit Court for the Fifteenth Judicial Circuit in and for Palm Beach County, Florida, against SkinCure Oncology, LLC (SkinCure) alleging breach of contract related to unpaid amounts owed for Sensus pr.
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
Price charts implemented using Lightweight Charts™